ONCOLOGY Vol 14 No 11
-
-
Thalidomide in the Management of Multiple Myeloma: The Arkansas Experience in > 300 Patients With Single-Agent and Combination Chemotherapy
-
Phase II Trial of Thalidomide for Treatment of Nonresectable Hepatocellular Carcinoma*
-
Implementing Recommendations for the Early Detection of Breast and Cervical Cancer Among Low-Income Women
-
Current Perspectives on Locally Advanced Pancreatic Cancer
-
Clinical Oncology, Second Edition
-
Thalidomide Modulates Vascular Endothelial Growth Factor Levels After Autologous Peripheral Blood Progenitor Cell Transplantation in Patients With Metastatic Breast Cancer
-
New Chemotherapy Regimen Far Less Toxic Than Standard Bladder Cancer Treatment
-
Local Recurrence After Mastectomy or Breast-Conserving Surgery and Radiation
-
Stress and Burnout in Oncology
-
Phase II Study of Thalidomide as an Antiangiogenic Agent in the Treatment of Recurrent Glioblastoma Multiforme
-
Current Perspectives on Locally Advanced Pancreatic Cancer
-
COMMENTARY
-
Early Diet May Play Important Role in Breast Cancer Risk
-
Stress and Burnout in Oncology
-
Local Recurrence After Mastectomy or Breast-Conserving Surgery and Radiation
-
Stress and Burnout in Oncology
-
Thalidomide-Induced Cessation of Weight Loss and Improved Sleep in Advanced Cancer Patients With Cachexia
-
Response of Metastatic Angiosarcoma to Thalidomide: Possible Synergism With Radiation Therapy
-
Screening for Ovarian Cancer: What We Know, What We Need to Know
-
Local Recurrence After Mastectomy or Breast-Conserving Surgery and Radiation
-
Novel Treatment Option in Older Patients With Relapsed Lung Cancer: Weekly Docetaxel
-
Current Perspectives on Locally Advanced Pancreatic Cancer
-
Research on Thalidomide in Solid Tumors, Hematologic Malignancies, and Supportive Care
-
Encouraging Improvement in Cytopenias of Patients With Myelodysplastic Syndromes With Thalidomide
-
Pilot and Safety Trial of Carboplatin, Paclitaxel, and Thalidomide in Advanced Non–Small-Cell Lung Cancer
-
The FDA Experience on the Use of Thalidomide in Advanced Malignancies
-
Screening for Ovarian Cancer: What We Know, What We Need to Know
-
Activity of Thalidomide in Waldenström’s Macroglobulinemia
-
Thalidomide Treatment of Metastatic Renal-Cell Carcinoma
-
Higher Doses of Methotrexate Dramatically Improve Survival in Some Lymphoma Patients
-
Three-Arm Phase II Study of Temozolomide in Metastatic Melanoma: Preliminary Results
-
Medicare Coverage of Clinical Trials
-
Clarithromycin, Low-Dose Thalidomide, and Dexamethasone Produces Consistent Responses in Myeloma and Waldenstrom’s Macroglobulinemia
-
Antinausea Cancer Treatment Shows Promise for Alcoholics
-
Phase II Trial of Thalidomide in the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
-
Screening for Ovarian Cancer: What We Know, What We Need to Know
-
HCFA Backs Off of Reimbursement Cuts for Oncology Drugs
-
COMMENTARY
-
Screening for Ovarian Cancer: What We Know, What We Need to Know
|
|
